Integrin alpha 3 beta 1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells
- PMID: 8930900
- PMCID: PMC276026
- DOI: 10.1091/mbc.7.11.1789
Integrin alpha 3 beta 1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells
Abstract
The mechanisms and receptors involved in phagocytosis by nonhematopoietic cells are not well understood. The involvement of the alpha 3 beta 1 integrin in phagocytosis of the extracellular matrix by human breast cancer cells was studied. The possible role of this integrin was suggested since alpha 3 and beta 1 but not alpha 2 subunits are concentrated at membrane sites where local degradation of fluorescently labeled gelatin occurs. Strikingly, anti-alpha 3 integrin monoclonal antibodies (mAbs) stimulate the phagocytosis of fluorescently labeled gelatin films, gelatin beads, and Matrigel films in a quantitative phagocytosis assay. Stimulation of the gelatin uptake by the anti-alpha 3 mAb is dose responsive, saturable, and time dependent. Antibodies against other integrin subunits have a lower stimulatory effect (anti-beta 1) or no significant effect (anti-alpha 2, -alpha 5, -alpha 6, and -alpha v) on gelatin phagocytosis. The synthetic HGD-6 human laminin peptide that binds specifically the alpha 3 beta 1 integrin, but not the scrambled HSGD-6 control peptide, also markedly stimulates gelatin uptake in a dose-responsive way. Furthermore, the stimulatory effects of the HGD-6 peptide and the anti-alpha 3 mAb are additive, suggesting that they might promote phagocytosis in different ways. Other laminin (YIGSR, IKVAV) and fibronectin (GRGDS) peptides have no effect on gelatin phagocytosis. Immunofluorescence shows that the alpha 3 and the beta 1, but not the alpha 2 integrin subunit, concentrate into patches on the cell surface after treatment with their respective mAbs. And, both gelatin and the alpha 3 beta 1 but not the alpha 2 beta 1 integrin are cointernalized and routed to acidic vesicles such as lysosomes. In conclusion, we demonstrate that human breast cancer cells locally degrade and phagocytose the extracellular matrix and show for the first time that the alpha 3 beta 1 integrin participates in this phagocytosis. We hypothesize that the anti-alpha 3 antibodies and the laminin peptide HGD-6 activate the alpha 3 beta 1 integrin, which results in a downstream signaling cascade stimulating phagocytosis.
Similar articles
-
A synthetic peptide derived from the carboxy terminus of the laminin A chain represents a binding site for the alpha 3 beta 1 integrin.J Cell Biol. 1992 Apr;117(2):449-59. doi: 10.1083/jcb.117.2.449. J Cell Biol. 1992. PMID: 1560034 Free PMC article.
-
A novel recognition site on laminin for the alpha 3 beta 1 integrin.Exp Cell Res. 1996 Feb 1;222(2):281-90. doi: 10.1006/excr.1996.0036. Exp Cell Res. 1996. PMID: 8598215
-
The alpha3 laminin subunit, alpha6beta4 and alpha3beta1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin.J Cell Sci. 1999 Aug;112 ( Pt 16):2615-29. doi: 10.1242/jcs.112.16.2615. J Cell Sci. 1999. PMID: 10413670
-
The integrin alpha 6 beta 4 and the biology of carcinoma.Biochem Cell Biol. 1996;74(6):811-21. doi: 10.1139/o96-087. Biochem Cell Biol. 1996. PMID: 9164650 Review.
-
Laminin-111-derived peptides and cancer.Cell Adh Migr. 2013 Jan-Feb;7(1):150-256. doi: 10.4161/cam.22827. Epub 2012 Dec 21. Cell Adh Migr. 2013. PMID: 23263633 Free PMC article. Review.
Cited by
-
Discovery and Targeting of a Noncanonical Mechanism of Sarcoma Resistance to ADI-PEG20 Mediated by the Microenvironment.Clin Cancer Res. 2023 Aug 15;29(16):3189-3202. doi: 10.1158/1078-0432.CCR-22-2642. Clin Cancer Res. 2023. PMID: 37339179 Free PMC article.
-
Collagen Remodeling along Cancer Progression Providing a Novel Opportunity for Cancer Diagnosis and Treatment.Int J Mol Sci. 2022 Sep 10;23(18):10509. doi: 10.3390/ijms231810509. Int J Mol Sci. 2022. PMID: 36142424 Free PMC article. Review.
-
Innate and adaptive resistance mechanisms to arginine deprivation therapies in sarcoma and other cancers.Cancer Drug Resist. 2019 Sep 19;2(3):516-526. doi: 10.20517/cdr.2019.49. eCollection 2019. Cancer Drug Resist. 2019. PMID: 35582579 Free PMC article. Review.
-
Extracellular Matrix Recycling as a Novel Plasticity Mechanism With a Potential Role in Disease.Front Cell Neurosci. 2022 Mar 31;16:854897. doi: 10.3389/fncel.2022.854897. eCollection 2022. Front Cell Neurosci. 2022. PMID: 35431813 Free PMC article. Review.
-
The Synaptic Extracellular Matrix: Long-Lived, Stable, and Still Remarkably Dynamic.Front Synaptic Neurosci. 2022 Mar 8;14:854956. doi: 10.3389/fnsyn.2022.854956. eCollection 2022. Front Synaptic Neurosci. 2022. PMID: 35350469 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
